BERTHOLET DESIR: Open Payments
NPI 1730108390 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,910 in 109 payments from 12 companies in 2025. Trend: 2023 $2,272 · 2024 $2,114 · 2025 $2,910
Food & beverage: $2,897Education: $13
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $561 |
| Vanda Pharmaceuticals Inc. | 21 | $446 |
| Alkermes, Inc. | 15 | $361 |
| Otsuka America Pharmaceutical, Inc. | 18 | $339 |
| Lundbeck LLC | 13 | $273 |
| Neurocrine BioSciences, Inc. | 7 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $222 |
| ABBVIE INC. | 9 | $184 |
| Luye Pharma (USA) Ltd. | 1 | $130 |
| Almatica Pharma LLC | 2 | $49 |
Products named: COBENFY, ABILIFY ASIMTUFII, FANAPT, ARISTADA, INGREZZA, CAPLYTA, VRAYLAR, ERZOFRI EXTENDED-RELEASE.
Industry payments across NY — which companies pay providers there.
